期刊文献+

间充质干细胞组织特异性归巢的研究进展 被引量:1

Advances in research for the organ-specific migration of mesenchymal stromal cells
原文传递
导出
摘要 间充质干细胞(MSCs)是一种非造血组织的多能干细胞,具有自我更新和多向分化的潜能,在机体组织再生和炎症控制的过程中发挥关键作用。其中,以MSCs为基础的治疗,其疗效至少部分取决于对所需细胞部位的特定归巢。然而,最近许多研究发现MSCs对不同组织的归巢特性存在差异,在一定程度上影响了MSCs发挥治疗作用。因此本文对MSCs在骨髓、脾和淋巴结、肠、心脏、肿瘤、多脏器的归巢现象和治疗作用、归巢的影响因素以及体内示踪技术进行了综述。 As non- hcmatopoietic multipotent stem cells, mesenchymal stem cells (MSCs) with the potential of selfrenewal and multi - direc- tional differentiation, play a key role in the process of tissue regenerations and anti - inflammation. In the case, the efficacy of these MSC - based therapies at least partly depends on specific homing towards the site where the cells are needed. Nowdays, many studies find that the different homing characteristics in different organizations, which limits the thera- peutic efficacy when they are used in stem cell therapy. Thus,the homing phenomena, the therapeutical efficacy, the influencing factors and the cell tracing techniques of MSCs in bone marrow, spleen and lymph nodes, intes- tine, heart, cancer and multiple organ are reviewed in the article.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2017年第17期1717-1720,共4页 The Chinese Journal of Clinical Pharmacology
基金 国家自然科学基金资助项目(81471040) 重庆市基础与前沿研究计划重点基金资助项目(cstc2015jcyj BX0138)
关键词 归巢 间充质干细胞 影响因素 细胞示踪 homing mesenchymal stem cell influencing factor celltracking
  • 相关文献

参考文献1

二级参考文献25

  • 1Figliuzzi M, Cornolti R, Perico N,et al.Bone marrow-derived mesenchymal stem cells improve islet graft function in diabetic rats.Transplant Proc. 2009;41 (5): 1797-1800.
  • 2Smiler D, Soltan M, Albitar M.Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.Implant Dent. 2008; 17(3):236-247.
  • 3Horie M, Sekiya I, Muneta T, et al.lntra-articular Injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization to distant organs in rat massive meniscal defect.Stem Cells. 2009;27(4): 878-887.
  • 4Castano-lzquierdo H, Alvarez-Barreto J, van den Dolder J, et aI.Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential.J Biomed Mater Res A. 2007;82(1 ):129-138.
  • 5Guhathakurta S, Subramanyan UR, Balasundari R, et al. Stem cell experiments and initial clinical trial of cellular cardiomyoplasty. Asian Cardiovasc Thorac Ann. 2009; 17(6):581-856.
  • 6Venkataramana NK, Kumar SK, Balaraju S, et al. Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res. 2010;155(2):62-70.
  • 7Tay CY, Yu H, Pal M, et al. Micropatterned matrix directs differentiation of human mesenchymal stem cells towards myocardial lineage. Exp Cell Res. 2010; 316 (7):1159-1168.
  • 8Yang Y J, Qian HY, Huang J, et al. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts. Arterioscler Thromb Vasc Biol, 2009;29(12):2076-2082.
  • 9Battiwalla M, Hematti P. Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009;11(5):503-515.
  • 10Huang NF, Lam A, Fang Q, et al. Bone marrow-derived mesenchymal stem cells in fibdn augment angiogenesis in the chronically infarcted myocardium. Regen Med.2009;4(4):527-538.

共引文献10

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部